Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Differential gene expression identifies subgroups of ovarian carcinoma.

Skubitz AP, Pambuccian SE, Argenta PA, Skubitz KM.

Transl Res. 2006 Nov;148(5):223-48.

PMID:
17145569
2.

Differential gene expression identifies subgroups of renal cell carcinoma.

Skubitz KM, Zimmermann W, Kammerer R, Pambuccian S, Skubitz AP.

J Lab Clin Med. 2006 May;147(5):250-67. Erratum in: J Lab Clin Med. 2007 Mar;149(3):163. Zimmerman, Wolfgang [corrected to Zimmermann, Wolfgang].

PMID:
16697773
3.

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.

Chien J, Fan JB, Bell DA, April C, Klotzle B, Ota T, Lingle WL, Gonzalez Bosquet J, Shridhar V, Hartmann LC.

Gynecol Oncol. 2009 Jul;114(1):3-11. doi: 10.1016/j.ygyno.2009.04.002. Epub 2009 May 1.

PMID:
19410283
4.

Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Hibbs K, Skubitz KM, Pambuccian SE, Casey RC, Burleson KM, Oegema TR Jr, Thiele JJ, Grindle SM, Bliss RL, Skubitz AP.

Am J Pathol. 2004 Aug;165(2):397-414.

5.

Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.

Curry EW, Stronach EA, Rama NR, Wang YY, Gabra H, El-Bahrawy MA.

Mod Pathol. 2014 Mar;27(3):433-42. doi: 10.1038/modpathol.2013.130. Epub 2013 Aug 16.

6.

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ.

Cancer Res. 2005 Nov 15;65(22):10602-12.

7.

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.

Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):690-700.

8.

Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.

Grisaru D, Hauspy J, Prasad M, Albert M, Murphy KJ, Covens A, Macgregor PF, Rosen B.

Oncol Rep. 2007 Dec;18(6):1347-56.

PMID:
17982616
9.

Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.

Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.

Gynecol Oncol. 2006 Nov;103(2):405-16. Epub 2006 May 24.

PMID:
16725184
10.

Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.

Pamuła-Piłat J, Rubel T, Rzepecka IK, Olbryt M, Herok R, Dansonka-Mieszkowska A, Grzybowska E, Kupryjańczyk J.

J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):659-74.

PMID:
25620176
11.

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.

Skubitz KM, Pambuccian S, Manivel JC, Skubitz AP.

J Transl Med. 2008 May 6;6:23. doi: 10.1186/1479-5876-6-23.

12.

Differential gene expression analysis of ovarian cancer in a population isolate.

Grazio D, Pichler I, Fuchsberger C, Zolezzi F, Guarnieri P, Heidegger H, Scherer A, Engl B, Messini S, Egarter-Vigl E, Pramstaller PP.

Eur J Gynaecol Oncol. 2008;29(4):357-63.

PMID:
18714569
13.

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1176-81.

14.

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.

Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J.

Clin Cancer Res. 2005 Sep 1;11(17):6300-10.

15.

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.

Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S.

Int J Cancer. 2004 Oct 20;112(1):14-25.

16.

Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.

Merritt MA, Parsons PG, Newton TR, Martyn AC, Webb PM, Green AC, Papadimos DJ, Boyle GM.

BMC Cancer. 2009 Oct 23;9:378. doi: 10.1186/1471-2407-9-378.

17.

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

Gilks CB, Vanderhyden BC, Zhu S, van de Rijn M, Longacre TA.

Gynecol Oncol. 2005 Mar;96(3):684-94.

PMID:
15721412
18.

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.

Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Gokden M, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S.

Br J Cancer. 2004 May 4;90(9):1814-24.

19.

Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.

Kolbe DL, DeLoia JA, Porter-Gill P, Strange M, Petrykowska HM, Guirguis A, Krivak TC, Brody LC, Elnitski L.

PLoS One. 2012;7(3):e32941. doi: 10.1371/journal.pone.0032941. Epub 2012 Mar 5.

20.

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.

King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, Mok SC, Gershenson DM, Wong KK.

Am J Surg Pathol. 2011 Jun;35(6):904-12. doi: 10.1097/PAS.0b013e318212ae22.

Supplemental Content

Support Center